A Multiple Sclerosis programme at Stem Plus in Sofia is €3,000–€8,000, versus roughly €14,600–€46,000 in the Netherlands. About 2.9h from Amsterdam, inside the EU, visa-free.
If you are researching Multiple Sclerosis treatment from the Netherlands, the obstacle is usually access or cost: standard options have plateaued, and regenerative therapy at home runs to €14,600–€46,000. Stem Plus offers the same European GMP standard for a fraction of that — and an easy, mostly visa-free trip.
Multiple sclerosis arises from immune-mediated attack on myelin and oligodendrocytes in the central nervous system, causing demyelination and axonal loss. Stem-cell strategies target both immune dysregulation and repair: placental mesenchymal stem cells are studied for their capacity to calm autoreactive immune cells and secrete neuroprotective factors, while neurogenic cells are explored for remyelination and axonal support. Preclinical work suggests stem cells migrate toward lesions and release anti-inflammatory mediators. Trials have enrolled relapsing-remitting and progressive forms, but the mechanism of any benefit is incompletely characterised, and no approach yet reverses established disability or halts long-term progression in humans. It is delivered under a physician-led protocol and designed to complement your existing care.
| Netherlands (home) | Stem Plus · EU | |
|---|---|---|
| Multiple Sclerosis treatment | €14,600–€46,000 | €3,000–€8,000 |
| Regulation | varies | EU · GMP |
| Flight to Sofia | 2.9h from Amsterdam | — |
This note is general information for planning, not legal or medical advice. Confirm entry rules for your nationality before booking.
Cost ranges are indicative market figures for planning, not quotes.
طب تجديدي معتمد GMP في قلب الاتحاد الأوروبي — من 3,000 إلى 8,000 يورو، جزء بسيط من أسعار أمريكا أو ألمانيا. بروتوكولات مخصصة لمرضى من أكثر من 50 دولة.
مراجعة طبية مجانية